The effect of increased fetal hemoglobin production on the frequency of vaso-occlusive crisis in sickle cell disease.
D000755:Anemia, Sickle Cell / Q000097:blood / Q000150:complications* / Q000188:drug therapy; D001374:Azacitidine / Q000627:therapeutic use; D002499:Centrifugation, Density Gradient; D004912:Erythrocytes / Q000473:pathology; D005319:Fetal Hemoglobin / Q000032:analysis*; D006801:Humans; D006918:Hydroxyurea / Q000627:therapeutic use; D007238:Infarction / Q000209:etiology*; D010146:Pain / Q000209:etiology
D005319:Fetal Hemoglobin; D001374:Azacitidine; D006918:Hydroxyurea